210 related articles for article (PubMed ID: 28838272)
1. Molecular mechanisms and clinical implications of miRNAs in drug resistance of esophageal cancer.
Yang W; Ma J; Zhou W; Zhou X; Cao B; Zhang H; Zhao Q; Fan D; Hong L
Expert Rev Gastroenterol Hepatol; 2017 Dec; 11(12):1151-1163. PubMed ID: 28838272
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance-related microRNAs in esophageal cancer.
Hong L; Han Y; Lu Q; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2012 Nov; 12(11):1487-94. PubMed ID: 22827640
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer.
Yang W; Ma J; Zhou W; Cao B; Zhou X; Yang Z; Zhang H; Zhao Q; Fan D; Hong L
Expert Opin Ther Targets; 2017 Nov; 21(11):1063-1075. PubMed ID: 28994330
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in gastrointestinal cancer: prognostic significance and potential role in chemoresistance.
Hong L; Han Y; Yang J; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Aug; 14(8):1103-11. PubMed ID: 24707835
[TBL] [Abstract][Full Text] [Related]
5. Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer.
Hemmatzadeh M; Mohammadi H; Karimi M; Musavishenas MH; Baradaran B
Biomed Pharmacother; 2016 Aug; 82():509-19. PubMed ID: 27470391
[TBL] [Abstract][Full Text] [Related]
6. Research of the mechanism on miRNA193 in exosomes promotes cisplatin resistance in esophageal cancer cells.
Shi S; Huang X; Ma X; Zhu X; Zhang Q
PLoS One; 2020; 15(5):e0225290. PubMed ID: 32369495
[TBL] [Abstract][Full Text] [Related]
7. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
Xie L; Jing R; Qi J; Lin Z; Ju S
Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
[TBL] [Abstract][Full Text] [Related]
8. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
[TBL] [Abstract][Full Text] [Related]
9. Prognosis-related microRNAs in esophageal cancer.
Hong L; Han Y; Zhang H; Zhao Q; Wu K; Fan D
Expert Opin Biol Ther; 2014 Apr; 14(4):483-9. PubMed ID: 24506707
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.
Hamano R; Miyata H; Yamasaki M; Kurokawa Y; Hara J; Moon JH; Nakajima K; Takiguchi S; Fujiwara Y; Mori M; Doki Y
Clin Cancer Res; 2011 May; 17(9):3029-38. PubMed ID: 21248297
[TBL] [Abstract][Full Text] [Related]
11. α-solanine enhances the chemosensitivity of esophageal cancer cells by inducing microRNA‑138 expression.
Wu J; Wang L; Du X; Sun Q; Wang Y; Li M; Zang W; Liu K; Zhao G
Oncol Rep; 2018 Mar; 39(3):1163-1172. PubMed ID: 29328459
[TBL] [Abstract][Full Text] [Related]
12. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
13. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
14. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer.
Kestens C; Siersema PD; van Baal JW
World J Gastroenterol; 2016 Jan; 22(1):1-7. PubMed ID: 26755856
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy.
Ko MA; Zehong G; Virtanen C; Guindi M; Waddell TK; Keshavjee S; Darling GE
Ann Thorac Surg; 2012 Oct; 94(4):1094-102; discussion 1102-3. PubMed ID: 22939244
[TBL] [Abstract][Full Text] [Related]
16. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
17. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer.
Riquelme I; Letelier P; Riffo-Campos AL; Brebi P; Roa JC
Int J Mol Sci; 2016 Mar; 17(3):424. PubMed ID: 27011182
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-induced drug resistance in gastric cancer.
Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer.
Duan L; Yang W; Feng W; Cao L; Wang X; Niu L; Li Y; Zhou W; Zhang Y; Liu J; Zhang H; Zhao Q; Hong L; Fan D
Ther Adv Med Oncol; 2020; 12():1758835920947342. PubMed ID: 32922521
[TBL] [Abstract][Full Text] [Related]
20. Function of miRNA in controlling drug resistance of human cancers.
Hong L; Yang Z; Ma J; Fan D
Curr Drug Targets; 2013 Sep; 14(10):1118-27. PubMed ID: 23834156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
